FI762258A - - Google Patents

Info

Publication number
FI762258A
FI762258A FI762258A FI762258A FI762258A FI 762258 A FI762258 A FI 762258A FI 762258 A FI762258 A FI 762258A FI 762258 A FI762258 A FI 762258A FI 762258 A FI762258 A FI 762258A
Authority
FI
Finland
Application number
FI762258A
Other languages
Finnish (fi)
Other versions
FI63751B (fi
FI63751C (fi
Inventor
Franz Troxler
Fritz Seemann
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI762258A publication Critical patent/FI762258A/fi
Publication of FI63751B publication Critical patent/FI63751B/fi
Application granted granted Critical
Publication of FI63751C publication Critical patent/FI63751C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
FI762258A 1975-08-15 1976-08-06 Analogifoerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-(3-tert-butylaminopropoxi)-2-metyl-indolderivat FI63751C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1071475 1975-08-15
CH1071475 1975-08-15

Publications (3)

Publication Number Publication Date
FI762258A true FI762258A (nl) 1977-02-16
FI63751B FI63751B (fi) 1983-04-29
FI63751C FI63751C (fi) 1983-08-10

Family

ID=4366041

Family Applications (1)

Application Number Title Priority Date Filing Date
FI762258A FI63751C (fi) 1975-08-15 1976-08-06 Analogifoerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-(3-tert-butylaminopropoxi)-2-metyl-indolderivat

Country Status (28)

Country Link
US (1) US4434176A (nl)
JP (2) JPS5223073A (nl)
AT (1) AT363070B (nl)
AU (1) AU505719B2 (nl)
BE (1) BE845197R (nl)
CA (1) CA1080720A (nl)
CY (1) CY1225A (nl)
DE (1) DE2635209C2 (nl)
DK (1) DK152120C (nl)
ES (1) ES450681A1 (nl)
FI (1) FI63751C (nl)
FR (1) FR2320743A2 (nl)
GB (2) GB1575510A (nl)
HK (1) HK35884A (nl)
IE (1) IE43797B1 (nl)
IL (2) IL50263A (nl)
KE (1) KE3404A (nl)
MY (1) MY8500135A (nl)
NL (2) NL176362C (nl)
NO (1) NO762735L (nl)
NZ (1) NZ181764A (nl)
PH (1) PH13356A (nl)
PT (1) PT65477B (nl)
SE (1) SE414633B (nl)
SG (1) SG84883G (nl)
SU (1) SU649313A3 (nl)
YU (1) YU198876A (nl)
ZA (1) ZA764883B (nl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2830211A1 (de) * 1977-07-21 1979-02-01 Sandoz Ag Substituierte indol-derivate, ihre herstellung und verwendung
JPS58106499A (ja) * 1981-12-19 1983-06-24 株式会社東芝 燃料交換装置のクランプ解除機構
NL8600137A (nl) * 1985-02-05 1986-09-01 Sandoz Ag Farmaceutische preparaten die desgewenst met een diureticum gecombineerde 3-aminopropoxyindolen bevatten, alsmede werkwijzen voor het toepassen van deze preparaten.
US5174210A (en) * 1990-04-27 1992-12-29 Heidelberger Druckmaschinen Aktiengesellschaft Preparation of the inking unit of a printing press for a change of printing job
EP0750608A1 (en) * 1994-01-28 1997-01-02 Cal International Limited Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker
GEP20084406B (en) * 2003-05-30 2008-06-25 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as hmg-co inhibitors
AU2006313430B2 (en) * 2005-11-08 2012-09-06 Ranbaxy Laboratories Limited Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
WO2008020314A2 (en) * 2006-03-14 2008-02-21 Ranbaxy Laboratories Limited Statin stabilizing dosage formulations
AU2007274724B2 (en) * 2006-07-14 2012-07-26 Ranbaxy Laboratories Limited Polymorphic forms of an HMG-CoA reductase inhibitor and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3751429A (en) * 1970-03-24 1973-08-07 Sandoz Ltd 4-(3-amino-2-substituted propoxy)indole derivatives
CH532040A (de) * 1970-03-24 1972-12-31 Sandoz Ag Verfahren zur Herstellung neuer Indolderivate
SE375771B (nl) * 1970-09-30 1975-04-28 Sandoz Ag
CH545784A (en) * 1971-01-07 1974-02-15 Beta blocking and anti-arrhythmic indole derivs - prepd by catalytic de-benzylation of 4-(3-benzyl aminopropoxy) indoles
CH545783A (en) * 1971-01-07 1974-02-15 Novel indole derivs - prepn by reacting 4-(2-hydroxy-3-isopropylaminopropoxy) indoles and acid anhy-drides

Also Published As

Publication number Publication date
JPS5649318A (en) 1981-05-02
CA1080720A (en) 1980-07-01
NL7608902A (nl) 1977-02-17
HK35884A (en) 1984-05-04
FI63751B (fi) 1983-04-29
DE2635209A1 (de) 1977-02-24
FR2320743A2 (fr) 1977-03-11
YU198876A (en) 1982-05-31
SU649313A3 (ru) 1979-02-25
FI63751C (fi) 1983-08-10
DK357576A (da) 1977-02-16
SE414633B (sv) 1980-08-11
IE43797B1 (en) 1981-06-03
BE845197R (fr) 1977-02-14
ZA764883B (en) 1978-03-29
NZ181764A (en) 1978-06-20
PT65477B (fr) 1978-05-10
IL50263A (en) 1980-06-30
FR2320743B2 (nl) 1978-11-17
CY1225A (en) 1984-04-06
PH13356A (en) 1980-03-20
PT65477A (fr) 1976-09-01
NL930134I2 (nl) 1996-11-01
DK152120C (da) 1988-06-20
SG84883G (en) 1985-01-11
AU505719B2 (en) 1979-11-29
IL50263A0 (en) 1976-10-31
US4434176A (en) 1984-02-28
IL58163A0 (en) 1979-12-30
JPS5223073A (en) 1977-02-21
IE43797L (en) 1977-02-15
NL176362C (nl) 1985-04-01
KE3404A (en) 1985-02-01
DE2635209C2 (de) 1983-01-27
JPS568834B2 (nl) 1981-02-25
NO762735L (nl) 1977-02-16
AT363070B (de) 1981-07-10
DK152120B (da) 1988-02-01
GB1575510A (en) 1980-09-24
ATA602576A (de) 1980-12-15
NL176362B (nl) 1984-11-01
MY8500135A (en) 1985-12-31
NL930134I1 (nl) 1993-11-01
AU1684176A (en) 1978-02-16
GB1575509A (en) 1980-09-24
SE7608865L (sv) 1977-02-16
ES450681A1 (es) 1977-11-16

Similar Documents

Publication Publication Date Title
FR2320743B2 (nl)
JPS5749267B2 (nl)
JPS5536959B2 (nl)
AU495933B2 (nl)
AU477418B2 (nl)
JPS5530812Y2 (nl)
JPS5628122B2 (nl)
JPS5515174B2 (nl)
JPS51147809U (nl)
CH582379B5 (nl)
CH587973A5 (nl)
BG21723A1 (nl)
BG22500A1 (nl)
BG23412A1 (nl)
BG26729A1 (nl)
BG22005A1 (nl)
CH27475A4 (nl)
BG22186A1 (nl)
CH576087A5 (nl)
BG22187A1 (nl)
CH576760A5 (nl)
CH577556A5 (nl)
CH592404A5 (nl)
CH584087A5 (nl)
CH584777A5 (nl)

Legal Events

Date Code Title Description
MA Patent expired
MA Patent expired

Owner name: SANDOZ AG